A life-long antiretroviral treatment of congenital HIV disease, associated with a mixed fat redistribution syndrome and osteopenia already occurred during pre-pubertal age

International Journal of STD and AIDS

Volumn 13, Issue 7, 2002, Pages 504-507

  Manfredi, Roberto ^a   Calza, Leonardo ^a   Chiodo, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiretroviral therapy; Congenital HIV disease; Lipodystrophy; Metabolic abnormalities; Osteopenia

Indexed keywords

ANTIRETROVIRUS AGENT;

ADIPOSE TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; CHILD; COMORBIDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MALE; METABOLIC DISORDER; OSTEOPENIA; PREPUBERTY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; VIRUS RESISTANCE;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE DISEASES, METABOLIC; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; MALE; RISK FACTORS; SYNDROME;

EID: 0036310819     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/09564620260079699     Document Type: Article

References (14)

1. Pathogenesis of HIV-1-protease-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
2. Metabolic disorders among HIV-infected patients treated with protease inhibitors: A review
3. HIV-associated lipodystrophy syndrome
4. Lipodystrophy syndrome in HIV infection: What is it, what causes it and how can it be managed?
5. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
6. Increased abnormal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy
7. Accelerated bone mineral loss in HIV-infected patient receiving potent antiretroviral therapy
8. Paediatric HIV infection - Diagnostic and epidemiological aspects
9. Visceral obesity, hypertriglyceridemia and hypercortisolism in a boy with perinatally acquired HIV infection receiving protease inhibitor-containing antiviral treatment
10. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children
11. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study
12. Fatty acid composition of plasma lipids in HIV-infected children. Comparison with seroreverters
13. Generalized lipodystrophy, congenital and acquired (lipoatrophy)
14. Nutrition in paediatric human immunodeficiency virus infection